Novocure · 2 days ago
Care Coordinator I
United States
Full-time
Onsite
New Grad, Entry LevelNovocure is committed to making a difference in cancer treatment through their innovative therapy. The Care Coordinator I serves as a dedicated contact for patients and caregivers, ensuring they feel supported throughout their treatment journey by facilitating communication and providing logistical support.
BiotechnologyHealth CareMedical DeviceOncology
Responsibilities
Completes inbound and outbound phone calls
Interface directly with patients and caregivers to support their treatment journey by explaining device logistics, providing travel and technical support, and placing supply and equipment orders
Works to ensure patients feel valued, secure and confident with starting and staying on treatment
Comfortable offering and attending video calls with patients and caregivers
Data entry and documentation management via company specific CRM and ERP platforms according to SOPs
Operates under close direction of Care Center leadership
Provide occasional on-call coverage, on a rotating schedule, as needed outside of normal business hours (including weekends and holidays), and for scheduled team/company meetings or events
Qualification
Required
Basic knowledge of Medicare, managed care, third-party payers and Medicaid
Knowledge of Protected Health Information and The Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy and Security guidelines
Working knowledge of legal and regulatory environment, with corresponding Guidelines (ACHC, ACCME, AdvaMED, FDA)
Solid working knowledge in the use of Excel, Word, and Outlook
Ability to move equipment weighing up to 50 pounds
Access to a quiet and private work space with reliable internet and telecommunications infrastructure to support work
Preferred
2-year college degree
Patient-facing health care experience
Ability to speak and understand Spanish
Company
Novocure
An Oncology Company Pioneering a Novel Therapy for Solid Tumors
Founded in 2000
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$1BKey Investors
Pharmakon AdvisorsJP Morgan ChaseBioPharma Credit
2024-05-02Post Ipo Debt· $100M
2020-11-09Post Ipo Debt· $150M
2020-11-05Post Ipo Debt· $575M
Leadership Team
Asaf Danziger
Chief Executive Officer
Mike Ambrogi
Chief Operating Officer
Recent News
2026-01-03
2025-12-22
Company data provided by crunchbase